Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation

Ma'en Obeidat, Xuan Li, Stephen Burgess, Guohai Zhou, Nick Fishbane, Nadia N. Hansel, Yohan Bossé, Philippe Joubert, Ke Hao, David C. Nickle, Maarten van den Berge, Wim Timens, Michael H. Cho, Brian D. Hobbs, Kim de Jong, Marike Boezen, Rayjean J. Hung, Nicholas Rafaels, Rasika Mathias, Ingo Ruczinski, Terri H. Beaty, Kathleen C. Barnes, Peter D. Paré, Don D. Sin

Source: Eur Respir J, 50 (5) 1700657; 10.1183/13993003.00657-2017
Journal Issue: November
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ma'en Obeidat, Xuan Li, Stephen Burgess, Guohai Zhou, Nick Fishbane, Nadia N. Hansel, Yohan Bossé, Philippe Joubert, Ke Hao, David C. Nickle, Maarten van den Berge, Wim Timens, Michael H. Cho, Brian D. Hobbs, Kim de Jong, Marike Boezen, Rayjean J. Hung, Nicholas Rafaels, Rasika Mathias, Ingo Ruczinski, Terri H. Beaty, Kathleen C. Barnes, Peter D. Paré, Don D. Sin. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation. Eur Respir J, 50 (5) 1700657; 10.1183/13993003.00657-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammation biomarkers and risk of pulmonary hypertension: a Mendelian randomization study
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Plasma adiponectin and risk of asthma: observational and Mendelian randomization studies in up to 557,801 individuals
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Role of genetic factors in COPD (alpha-1-antitrypsin deficiency and other factors)
Source: Annual Congress 2005 - PG13 - COPD: genetic and environmental factors, epidemiology, socio-economic impact and preventative measures
Year: 2005


Late-breaking abstract: Surfactant protein D (SP-D) as a biomarker for mortality: A study in elderly Danish twins
Source: Annual Congress 2011 - Lung cell biology
Year: 2011

Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study
Source: Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020
Year: 2022



Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study
Source: Eur Respir J, 51 (6) 1800329; 10.1183/13993003.00329-2018
Year: 2018



Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate
Source: Eur Respir J 2010; 35: 768-775
Year: 2010



Age at menopause and lung function: A Mendelian randomization study
Source: International Congress 2018 – Role of omics in population studies
Year: 2018

Pilot: identification of rehospitalization risk factors for patients with COPD
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Age at menopause and lung function: a Mendelian randomisation study
Source: Eur Respir J, 54 (4) 1802421; 10.1183/13993003.02421-2018
Year: 2019



Intermediate and severe α1-antitrypsin deficiency: influence on plasma α1-antitrypsin, FEV1 and risk of COPD. Three meta-anlyses
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002

Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Is COPD a risk factor for diabetes?
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012

Genetic determinants of lung function in COPD: A genome-wide association study
Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD
Year: 2010

Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population
Source: Eur Respir J 2001; 18: 482-490
Year: 2001



CFTR and risk of pulmonary arterial hypertension: a case report and mendelian randomization study
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Systemic inflammation, genetic susceptibility and lung function
Source: Eur Respir J 2008; 32: 92-97
Year: 2008



COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013